Answers are grounded in this paper and cite their sources.
The toxicity of isoniazid (INH) used as a secondary chemoprophylactic agent was evaluated in 160 adults. Periodic clinical and liver-function evaluations were made during the year of treatment. Sixteen patients (10%) were unable to complete the therapy, 12 of these because of symptomatic reactions. The most frequent symptom complex included fever, myalgias, arthralgias, and nausea or anorexia. Associated elevation of the serum glutamic oxaloacetic transaminase (SGOT) level was frequent, but no patients developed clinical jaundice. The drug was also stopped in four asymptomatic patients because of elevation of the SGOT level to more than 100 units (upper limits of normal 40). The symptomatic reactions and liver-function test abnormalities tended to occur early in therapy. Efforts to detect toxicity should be concentrated in the early weeks of drug administration.
No takes yet. Share an insight, caveat, or question.
Richard B. Byrd (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: